Clinical Trial Update: Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and efficacy of Trans Sodium Crocetinate in combination with radiation and temozolomide for newly diagnosed glioblastoma; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Trans Sodium Crocetinate (trans-sodium crocetinate)

Snippet

Sponsor: Diffusion Pharmaceuticals Inc | Conditions: Glioblastoma, GBM | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-14